-
Literature of Cloud Clone products in Aug. 2020 (Excerpt)
In Aug. 2020, Literature of Cloud Clone products has exceeded 260. Cloud-Clone could provide multipleproteins, antibodies and ELISA kit, which has been praised by customers.(For more information, please visit: www.cloud-clone.com/www.uscnk.cn)
-
Cloud-Clone Is Coming!
CLOUD-CLONE CORP. (CCC, USA), a research and experimental development in molecular biology and immunology oriented company headquartered in Houston, is the owner of the trade mark “Cloud-Clone”. Its main business includesproduction of assay reagent, manufacture of analysis equipment and service for animal experiment.
-
Congratulations to professor Minjia Tan and professor Kenta Maruyama for publishing their paper on Cell.
On July 9, 2020, professor Minjia Tan from State Key Laboratory of Shanghai Institute of Materia Medica published a paper titled Integrative Proteomic Characterization of Human Lung Adenocarcinoma on Cell.Genomic studies of lung adenocarcinoma (LUAD) have advanced our understanding of the disease’s biology and accelerated targeted therapy. However, the proteomic characteristics of LUAD remain poorly understood. We carried out a comprehensive proteomics analysis of 103 cases of LUAD in Chinese patients. Integrative analysis of proteome, phosphoproteome, transcriptome, and whole-exome sequencing data revealed cancer-associated characteristics, such as tumor-associated protein variants,......
-
Literature of Cloud Clone products in JUL. 2020 (Excerpt)
In JUL. 2020, Literature of Cloud Clone products has exceeded 240. Cloud-Clone could provide multipleproteins, antibodies and ELISA kit, which has been praised by customers.(For more information, please visit: www.cloud-clone.com/www.uscnk.cn)
-
Literature of Cloud Clone products in Jun. 2020 (Excerpt)
In Jun. 2020, Literature of Cloud Clone products has exceeded 270. Cloud-Clone could provide multipleproteins, antibodies and ELISA kit, which has been praised by customers.(For more information, please visit: www.cloud-clone.com/www.uscnk.cn)
-
The common targets of SARS-CoV-2, SARS-CoV and MERS-CoV acting on the organism
In 2020, a new coronavirus, SARS-CoV-2, is sweeping the world. Infection of the organism can cause diseases with the respiratory system as the main symptom. The Middle East Respiratory Syndrome (MERS) in 2012 and Severe Acute Respiratory Syndrome (SARS) in 2002 were also caused by coronavirus infections, MERS-CoV and SARS-CoV, respectively.According to the genome structure of coronavirus,coronaviruses can be divided into four categories: α, β, γand δ.αand βonly infect mammals, γand δmainly infect poultry. SARS-CoV-2, SARS-CoVand MERS-CoVbelong to the βcategory. The genome structure is as follows:Figure 1. The genome structure of SARS-CoV-2, SARS-CoVand MERS-CoV1.SARS-CoV-2, SA......